Evidence map›Paper›PMID 24600403›Full record

ArticleFrontiers in physiology2014

Genetic silencing of Nrf2 enhances X-ROS in dysferlin-deficient muscle.

Ponvijay Kombairaju, Jaclyn P Kerr, Joseph A Roche, Stephen J P Pratt, Richard M Lovering, Thomas E Sussan, Jung-Hyun Kim, Guoli Shi, Shyam Biswal, Christopher W Ward

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Reductive stress in striated muscle cells.Cellular and molecular life sciences : CMLS · 2020
    Review
  6. International journal of molecular sciences · 2020
    Article
  7. Review
  8. Article
  9. Review
  10. Microtubule mechanics in the working myocyte.The Journal of physiology · 2017
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ponvijay KombairajuDepartment of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University Baltimore, MD, USA.
Jaclyn P KerrDepartment of Physiology, University of Maryland School of Medicine Baltimore, MD, USA.
Joseph A RocheDepartment of Physiology, University of Maryland School of Medicine Baltimore, MD, USA.
Stephen J P PrattDepartment of Orthopaedics, University of Maryland School of Medicine Baltimore, MD, USA.
Richard M LoveringDepartment of Orthopaedics, University of Maryland School of Medicine Baltimore, MD, USA.
Thomas E SussanDepartment of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University Baltimore, MD, USA.
Jung-Hyun KimDepartment of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University Baltimore, MD, USA.
Guoli ShiDepartment of Organizational Systems and Adult Health, University of Maryland School of Nursing Baltimore, MD, USA.
Shyam BiswalDepartment of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University Baltimore, MD, USA.
Christopher W WardDepartment of Organizational Systems and Adult Health, University of Maryland School of Nursing Baltimore, MD, USA.
University of Maryland, Baltimore · USJohns Hopkins University · US

Funding

TARGETING EARLY CHANGES FOR NEW SCREENING STRATEGIESP50CA058184 · NCI · JOHNS HOPKINS UNIVERSITY · PI BISWAL, SHYAM · 1992 to 2013
$30.5M
Oxidative Stress & Inflammation in a Human PM Nasal ChallengeP50ES015903 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI BREYSSE, PATRICK N · 2007 to 2011
$12.1M
Interdisciplinary Training Program Muscle BiologyT32AR007592 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI Aikaterini Kontrogianni-Konstantopoulos · 1996 to 2026
$11.7M
Regulation of Tumorigenesis and therapeutic resistance by Nrf2 in lung cancerR01CA140492 · NCI · JOHNS HOPKINS UNIVERSITY · PI BISWAL, SHYAM · 2010 to 2014
$1.8M
Mechanisms of Force Loss in Injured and Dystrophic Skeletal MuscleR01AR059179 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI LOVERING, RICHARD M · 2010 to 2014
$1.4M
Stretch Dependent Signaling in Dystrophic Skeletal MuscleR01AR062554 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI WARD, CHRISTOPHER WILLIAM · 2013 to 2014
$675k
NCI NIH HHS P50 CA058184NCI NIH HHS R01 CA140492NIAMS NIH HHS R01 AR059179NIAMS NIH HHS R01 AR062554NIAMS NIH HHS T32 AR007592NIEHS NIH HHS P50 ES015903
6 · The paper itself

Abstract

Oxidative stress is a critical disease modifier in the muscular dystrophies. Recently, we discovered a pathway by which mechanical stretch activates NADPH Oxidase 2 (Nox2) dependent ROS generation (X-ROS). Our work in dystrophic skeletal muscle revealed that X-ROS is excessive in dystrophin-deficient (mdx) skeletal muscle and contributes to muscle injury susceptibility, a hallmark of the dystrophic process. We also observed widespread alterations in the expression of genes associated with the X-ROS pathway and redox homeostasis in muscles from both Duchenne muscular dystrophy patients and mdx mice. As nuclear factor erythroid 2-related factor 2 (Nrf2) plays an essential role in the transcriptional regulation of genes involved in redox homeostasis, we hypothesized that Nrf2 deficiency may contribute to enhanced X-ROS signaling by reducing redox buffering. To directly test the effect of diminished Nrf2 activity, Nrf2 was genetically silenced in the A/J model of dysferlinopathy-a model with a mild histopathologic and functional phenotype. Nrf2-deficient A/J mice exhibited significant muscle-specific functional deficits, histopathologic abnormalities, and dramatically enhanced X-ROS compared to control A/J and WT mice, both with functional Nrf2. Having identified that reduced Nrf2 activity is a negative disease modifier, we propose that strategies targeting Nrf2 activation may address the generalized reduction in redox homeostasis to halt or slow dystrophic progression.

Indexed as

dysferlindystrophyNrf2ROSX-ROS

Identifiers

PMID24600403
PMCPMC3928547
OpenAlexW1987727905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.